Assessment of Prostate and Bladder Cancer Genomic Biomarkers Using Artificial Intelligence: a Systematic Review

被引：0

作者：

Andrey Bazarkin

Andrey Morozov

Alexander Androsov

Harun Fajkovic

Juan Gomez Rivas

Nirmish Singla

Svetlana Koroleva

Jeremy Yuen-Chun Teoh

Andrei V. Zvyagin

Shahrokh François Shariat

Bhaskar Somani

Dmitry Enikeev

机构：

[1] Sechenov University,Institute for Urology and Reproductive Health

[2] Sechenov University,Department of Pediatric Surgery, Division of Pediatric Urology and Andrology

[3] Medical University of Vienna,Department of Urology and Comprehensive Cancer Center

[4] Karl Landsteiner Institute of Urology and Andrology,Department of Urology

[5] Clinico San Carlos University Hospital,School of Medicine

[6] Brady Urological Institute,Clinical Institute for Children Health Named After N.F. Filatov

[7] Johns Hopkins Medicine,Department of Surgery

[8] Sechenov University,Institute of Molecular Theranostics

[9] S.H. Ho Urology Centre,Department of Urology

[10] The Chinese University of Hong Kong,Department of Urology

[11] Sechenov University,Department of Urology, Second Faculty of Medicine

[12] Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences,Division of Urology, Department of Special Surgery

[13] Weill Cornell Medical College,Department of Urology

[14] University of Texas Southwestern,Division of Urology

[15] Charles University,undefined

[16] Jordan University Hospital,undefined

[17] The University of Jordan,undefined

[18] University Hospital Southampton,undefined

[19] Rabin Medical Center,undefined

来源：

Current Urology Reports | 2024年 / 25卷

关键词：

Prostate cancer; Bladder cancer; Artificial intelligence; Differentially expressed genes; Genomics;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：19 / 35

页数：16

共 65 条

[11] Li J(2005)Structural basis for accommodation of nonsteroidal ligands in the androgen receptor J Biol Chem 280 37747-37754
[12] Lee S(2013)Enzalutamide: a novel antiandrogen for patients with castrate-resistant prostate cancer Clin Cancer Res 19 1335-1339
[13] Kerns S(2013)Enzalutamide for the treatment of prostate cancer Expert Opin Pharmacother 14 679-685
[14] Ostrer H(2005)Structural basis for antagonism and resistance of bicalutamide in prostate cancer Proc Natl Acad Sci U S A 102 6201-6206
[15] Rosenstein B(2012)ARN-509: a novel antiandrogen for prostate cancer treatment Cancer Res 72 1494-1503
[16] Deasy JO(2018)Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer Clin Genitourin Cancer 16 332-340
[17] Oh JH(2020)Deep learning modeling of androgen receptor responses to prostate cancer therapies Int J Mol Sci 21 1-11
[18] Hou Q(2016)Use of Artificial Intelligence and Machine Learning Algorithms with Gene Expression Profiling to Predict Recurrent Nonmuscle Invasive Urothelial Carcinoma of the Bladder J Urol 195 493-498
[19] Shamsara E(2014)Molecular subtyping of bladder cancer using Kohonen self-organizing maps Cancer Med 3 1225-1234
[20] Shamsara J(2010)The Application of Artificial Intelligence to Microarray Data: Identification of a Novel Gene Signature to Identify Bladder Cancer Progression Eur Urol 57 398-406

← 1 2 3 4 5 6 7 →